We are live on
!
Find out more
KCM
Kynam Capital Management Portfolio holdings
AUM
$1.58B
1-Year Est. Return
138.67%
This Fund
S&P 500
1 Year Est. Return
+138.67%
AUM
$1.58B
AUM Growth
+$39.5M
(+2.6%)
Holding
41
Top Buys
| 1 | +$45.1M | |
| 2 | +$34.5M | |
| 3 | +$31.4M | |
| 4 |
CytomX Therapeutics
CTMX
|
+$30.7M |
| 5 |
Legend Biotech
LEGN
|
+$30.1M |
Top Sells
| 1 | +$78.6M | |
| 2 | +$41.1M | |
| 3 | +$39.3M | |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
+$28.6M |
| 5 |
DVAX
Dynavax Technologies
DVAX
|
+$21.2M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
enGene Therapeutics
ENGN
$111M
| $9.24M | 0.59% |
1,356,843
-136,055
|
|
||
27
Design Therapeutics
DSGN
$653M
| $8.35M | 0.53% |
784,606
|
|
||
28
Wave Life Sciences
WVE
$1.1B
| $7M | 0.44% |
965,193
-1,203,912
|
|
||
|
CLYM
29
Climb Bio
CLYM
$617M
| $6.87M | 0.44% |
1,003,341
-25,000
|
|
||
|
AMRN
30
Amarin Corp
AMRN
$298M
| $6.83M | 0.43% |
472,382
+83,109
|
|
||
31
Biohaven
BHVN
$1.67B
| $5.95M | 0.38% |
702,884
|
|
||
32
Prelude Therapeutics
PRLD
$306M
| $5.45M | 0.35% |
1,592,551
+803,684
|
|
||
33
Caribou Biosciences
CRBU
$182M
| $4.76M | 0.3% |
2,503,302
|
|
||
34
Alector
ALEC
$182M
| $4.3M | 0.27% |
2,000,000
|
|
||
35
ProQR Therapeutics
PRQR
$161M
| $2.54M | 0.16% |
1,566,317
|
|
||
36
Candel Therapeutics
CADL
$623M
| $980K | 0.06% |
+200,000
|
|
||
37
CG Oncology
CGON
$4.8B
| – | – |
-945,830
|
|
||
|
DVAX
38
DELISTED
Dynavax Technologies
DVAX
| – | – |
-1,375,632
|
|
||
39
Omeros
OMER
$713M
| – | – |
0
|
|
||
40
Revolution Medicines
RVMD
$31.6B
| – | – |
0
|
|
||
41
Tyra Biosciences
TYRA
$1.59B
| – | – |
-1,564,492
|
|